Creative Biolabs-Immuno-oncology

Anti-DLL3 (clone SC1G6Z.4I) SynExpress pU-Cy3-I10-E Modified CD8+ T cells (CAT#: ITS-1224-CR2122)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DLL3 (clone SC1G6Z.4I). We employs the pX330 (pUC-Cy3-IL-10-EcoRI) vector components and the SynExpress system of the miRNA Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
DLL3
Clone
SC1G6Z.4I
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
pUC
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
miRNA
Carrier Type
pX330
Transformation Accuracy
0.87
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving